Interact to see
Advertisement
Advertisement
MUE vs NUV
MUE vs NUV Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
MUE vs. NUV commentary
Jul 28, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MUE is a Buy and NUV is a Hold.
SUMMARIES
FUNDAMENTALS
Fundamentals
NUV has more net assets: 1.83B vs. MUE (224M). NUV has a higher annual dividend yield than MUE: NUV (2.068) vs MUE (-3.025). MUE was incepted earlier than NUV: MUE (26 years) vs NUV (38 years). NUV (0.47) has a lower expense ratio than MUE (1.51). MUE has a higher turnover NUV (21.00) vs NUV (21.00).
| MUE | NUV | MUE / NUV | |
| Gain YTD | -3.025 | 2.068 | -146% |
| Net Assets | 224M | 1.83B | 12% |
| Total Expense Ratio | 1.51 | 0.47 | 321% |
| Turnover | 48.00 | 21.00 | 229% |
| Yield | 4.82 | 4.22 | 114% |
| Fund Existence | 26 years | 38 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| MUE | NUV | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 90% | 3 days ago 70% |
| Stochastic ODDS (%) | 3 days ago 79% | 3 days ago 82% |
| Momentum ODDS (%) | 3 days ago 72% | 3 days ago 69% |
| MACD ODDS (%) | 3 days ago 69% | 3 days ago 76% |
| TrendWeek ODDS (%) | 3 days ago 83% | 3 days ago 70% |
| TrendMonth ODDS (%) | 3 days ago 69% | 3 days ago 74% |
| Advances ODDS (%) | 3 days ago 85% | 3 days ago 76% |
| Declines ODDS (%) | 10 days ago 75% | 5 days ago 76% |
| BollingerBands ODDS (%) | 3 days ago 88% | 3 days ago 83% |
| Aroon ODDS (%) | 3 days ago 81% | 3 days ago 70% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ASVIX | 10.10 | 0.06 | +0.60% |
| American Century Small Cap Value Inv | |||
| VITSX | 152.68 | 0.67 | +0.44% |
| Vanguard Total Stock Market Idx I | |||
| GCLLX | 17.21 | 0.06 | +0.35% |
| Goldman Sachs Enhanced U.S. Equity C | |||
| VECRX | 22.33 | 0.07 | +0.31% |
| Virtus KAR Equity Income R6 | |||
| FBTTX | 25.58 | N/A | N/A |
| Fidelity Advisor Biotechnology M | |||